Watch this multi-stakeholder public working session held in the European Parliament, Brussels, on achieving healthcare system readiness and capacity for radioligand therapy in Europe.
This webinar discussion looks at current trends in R&D funding, clinical trials, innovation, and other topics related to R&D activity.
On behalf of MEP Niels Geuking (EPP, Germany), we would like to cordially invite you to attend a public working session on preparing European infrastructure and healthcare systems for the latest advances in cancer care. This is a hybrid event with attendance options in-person at the European Parliament in Brussels and virtually.
Learn about spending and usage of medicines in the past year and outlook to the future, globally and across specific therapy areas and countries.
Discover trends in drug approvals and launches, pipeline activity, and data on clinical trial activity.
Examine the state of the U.S. health system, medicine usage, drug pricing, and costs for patients.
Explore research and development in oncology and the progress being made to improve representativeness of race and ethnicity in clinical trial populations.
Video discussion between Michael Kleinrock, IQVIA Institute, and Craig Burton, Association for Accessible Medicines, on key findings in the IQVIA Institute’s report on Drug Shortages in the U.S. 2023.
Achieving Sustainable Levels of Biosimilar Competition in Europe
Interactions between patient organizations and life sciences companies.